Nordic Life Science 1
Are Your Western Blots Constant Or a Constant Sou
rce of Variability? adlego.se We perform GLP studies to characterize new drug candidates We have access to equipment for: Angiography IVIS Micro-PET MRI, CT Calorimetry Haematology Clinical chemistry Blood pressure Bioanalysis EKG BSL-3 containment Surgical interventions We perform studies to determine: DMPK Effect Toxicity ISO 10993 Histopathology Biocompatibility ISO15798 ON NN PCR, QPCR & NGS bibliotek SSSISLII FRLAAIOIOAAIOIO Smidig uppsäning av: III FI FILTRRRT N FTLTTT TTNNN Rob spar: - d - pengar - axlar & tummar I IN D WN TRE M OCESSING Högsta precision. Boka en demo eller presentaon! Enkel helautomasering av NGS bibliotekspreppar. ACSIA!! ACSIA med dedikerad programvara! Boka presentaon!! Kontakta oss på 08-560 361 90 eller info@techtum.se t MARTm/SMART SMART RT • Provpreparaon • PCR • qPCR • NGS • Diagnosska kit för onkologi (NGS) Get the answer at www.youdobio.com/SMART Get the answer at www.y uo dobio c. om/SMART www.techtum.se Get the answer at www.youdobio.com/SMART Get the answer at www.youdobio.com/SMART Ge ne r a l e nq u ir ie s : inf o @ crs t . f i w w w . crs t . f i Our clinical experience covers many pharmacodynamic variables in CNS, cardiovascular and metabolic disorders as well other areas. Surrogate endpoints used in pharma-codynamic studies are typically molecular biomarkers in biological fluids, imaging biomarkers, or clinical physiological or neuropsychological measures. We have experience from early, phase I-IIa efficacy studies as the main study site and from later, phase II-IV multi-centre studies as a clinical study site. licor.com/constant ROB: höjer nivån på noggrannhet, ekonomi och effektivitet i pipettering N D O SSSS AAAA P POCOC SSNG DE DED PRR POCS NGNG AAAA I OOO WN D IN D N N REE M RRE EEI II DE DEDDD???? WWNTRTETRMM Rob är enkel: a programmera för PCR & QPCRreakoner mm. Trevlig prisbild på robot och pipespetsar. CRST Oy iS run by experienced specialists with in-depth understanding of basic and clinical pharmacology and drug development including clinical management. CRST’s core expertise lies in the understanding of disease mechanisms. Specialists from different fields participate in CRST’s operations as principal investigators and scientific consultants. We have worked with 7/10 biggest pharma companies in addition to many small and midsize companies with excellent customer satisfaction, over 90% of customers return with next project. CRST’s services comprise clinical study design, study conduct and reporting, and regulatory affairs. Timing issues that make blots difficult to reproduce Limited normalization options that restrict your research We have over 20 years of experience in conducting clinical pharmacology studies (First in Human, SAD, MAD, Early Precision QT, BA/BE, interaction studies etc.) in healthy volunteers and patients. We use scientific expertise to support your company’s go/ no-go decisions by providing important clinical information on the behavior of your drug candidate. We are specialized in Phase I-II clinical studies that employ imaging and other biomarkers as surrogate endpoints. We have long experience in clinical trials involving PET imaging and access to over 40 tracers. Want to reduce variability? Get white papers and webinars from the Western blot experts. exCellenCe in pROving YOuR CONCEPT Very strong bands outside the linear dynamic range